Accumulating evidence showed that systemic inflammation was positively associated with various solid cancer types, including colorectal, gastric, and lung cancers.[14–16] Markers,[8,17–21] which have been commonly used, included C-reactive protein, neutrophil count, platelet count, prostate health index, modified Glasgow Prognostic Score, NLR, and PLR. Here, CRP is linked to lung carcinoma.